Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial
Publication
, Conference
Olson, JA; Gildy, BV; Unzeitig, G; Marcom, PK; Guenther, JM; Deshryver, K; Allred, C; Le-Petross, H; Suman, V; Hunt, KK; Ellis, MJ
Published in: ANNALS OF SURGICAL ONCOLOGY
February 1, 2012
Duke Scholars
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2012
Volume
19
Start / End Page
S6 / S7
Location
Orlando, FL
Publisher
SPRINGER
Conference Name
65th Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Olson, J. A., Gildy, B. V., Unzeitig, G., Marcom, P. K., Guenther, J. M., Deshryver, K., … Ellis, M. J. (2012). Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial. In ANNALS OF SURGICAL ONCOLOGY (Vol. 19, pp. S6–S7). Orlando, FL: SPRINGER.
Olson, J. A., B. V. Gildy, G. Unzeitig, P. K. Marcom, J. M. Guenther, K. Deshryver, C. Allred, et al. “Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial.” In ANNALS OF SURGICAL ONCOLOGY, 19:S6–7. SPRINGER, 2012.
Olson JA, Gildy BV, Unzeitig G, Marcom PK, Guenther JM, Deshryver K, et al. Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial. In: ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2012. p. S6–7.
Olson, J. A., et al. “Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial.” ANNALS OF SURGICAL ONCOLOGY, vol. 19, SPRINGER, 2012, pp. S6–7.
Olson JA, Gildy BV, Unzeitig G, Marcom PK, Guenther JM, Deshryver K, Allred C, Le-Petross H, Suman V, Hunt KK, Ellis MJ. Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial. ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2012. p. S6–S7.
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2012
Volume
19
Start / End Page
S6 / S7
Location
Orlando, FL
Publisher
SPRINGER
Conference Name
65th Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis